Is activation in inflammatory bowel diseases associated with further impairment of coronary microcirculation?

dc.authorid0000-0002-1901-5603
dc.authorid0000-0002-6219-1071
dc.contributor.authorÇalışkan, Zuhal
dc.contributor.authorKeles, Nursen
dc.contributor.authorGokturk, Huseyin Savas
dc.contributor.authorOzdil, Kamil
dc.contributor.authorAksu, Feyza
dc.contributor.authorOzturk, Oguzhan
dc.contributor.authorKahraman, Resul
dc.date.accessioned2025-05-10T19:49:42Z
dc.date.issued2016
dc.departmentİstanbul Medeniyet Üniversitesi
dc.description.abstractBackground: Inflammatory bowel disease [IBD] includes a number of chronic relapsing diseases. In IBD intestinal microvascular endothelial cells are damaged by an abnormal immune response. Several studies have shown that IBD may cause increment in risk of developing atherosclerosis. IBD in activation was related to enhanced risks of worse cardiovascular [CV] outcome, on the other hand no risk increment was seen in remission comparing to control group in those studies. Coronary FlowReserve [CFR] reflects coronary microvascular circulation. Coronary microvascular dysfunction may be defined as a predictor of CV outcome combined with previous described atherosclerotic risk factors. The present study was purposed to further evaluate whether or not CFR in the left anterior descending artery [LAD] is disturbed in IBD patients with activation in comparison to remission and healthy subjects. Methods: 62 patients with IBD and 39 healthy volunteers were enrolled into the study. Patients' demographics were recorded. CFR evaluation of patients with IBD in both activation and remission period and control group were performed with transthoracic echocardiography. Results: CFR was significantly lowest in the active period of the IBD [2.26 [2.08-2.55] vs. 2.55 [2.18-3.00] and 3.10 [2.85-3.29] p < 0.001]. CFR is negatively correlated with disease activity scores of IBD. Conclusion: This study showed that CFR is more prominently disturbed in patients with IBD in activation. The activation of disease may have a major role in the progression of coronary microcirculatory dysfunction and future cardiovascular events. (C) 2016 Elsevier Ireland Ltd. All rights reserved.
dc.identifier.doi10.1016/j.ijcard.2016.08.141
dc.identifier.endpage181
dc.identifier.issn0167-5273
dc.identifier.issn1874-1754
dc.identifier.pmid27541650
dc.identifier.scopus2-s2.0-84981710162
dc.identifier.scopusqualityQ1
dc.identifier.startpage176
dc.identifier.urihttps://doi.org/10.1016/j.ijcard.2016.08.141
dc.identifier.urihttps://hdl.handle.net/20.500.14730/12110
dc.identifier.volume223
dc.identifier.wosWOS:000387036200062
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherElsevier Ireland Ltd
dc.relation.ispartofInternational Journal of Cardiology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WOS_20250302
dc.subjectInflammatory bowel diseases
dc.subjectActivation
dc.subjectCoronary flow reserve
dc.titleIs activation in inflammatory bowel diseases associated with further impairment of coronary microcirculation?
dc.typeArticle

Dosyalar